Preparing solid samples reliably and rapidly - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Preparing solid samples reliably and rapidly
Manual sample preparation methods for solid dose pharmaceuticals have a number of inherent disadvantages, primarily because they are time consuming and unpredictable. Although automated technologies can overcome these problems to some extent, they too have limitations. A new instrument for tablet sample homogenization, however, offers an effective solution that produces high-quality samples using low volumes in a short time frame.


Pharmaceutical Technology Europe
Volume 21, Issue 12


(Martin Poole/Getty Images)
During the batch manufacture of solid dose pharmaceuticals, APIs are carefully combined with bulk materials to create the final product. The production of a uniformly distributed, highquality mixture, however, is a challenging process for several reasons:
  • the low ratio of API to bulk material
  • the production of unwanted byproducts during ingredient combination
  • the possible introduction of contaminants
  • mixing and temperature inconsistency.

Environmental factors, such as heat, moisture and light, may also affect the stability and quality of the final manufactured product.

All of these are important considerations for regulatory authorities, which makes stringent testing for dose content uniformity and potential contaminates an essential part of the manufacturing process to ensure the safety and effectiveness of pharmaceutical products. Unfortunately, preparing solid dose samples for product analysis is one of the most time-consuming tasks in analytical laboratories — partly because regulatory guidelines demand that large numbers of samples be prepared and tested. The introduction of more complex dose forms, such as controlled release, has also created further challenges.

The most commonly used method for solid dose sample analysis is HPLC, which separates, identifies and quantifies compounds. However, the solid dosage form must be first placed in a suitable solvent and prepared as a solution before HPLC analysis can be used.

Preparing the sample

There are several difficulties associated with the preparation of the sample solution; many solid dose forms are resistant to dissolution to enable them to pass into the stomach without breaking up, and special tablet coatings have also been developed that control the site of drug delivery in the digestive system. Further challenges are presented by controlled release dosage forms because they deliver the active ingredients with a specific dosing profile — in some cases releasing an active ingredient during a 24h period — making their dissolution a lengthy and complex process.

Disadvantages of manual methods

The manual solid–liquid extraction process can be accelerated using a number of methods, including manual grinding, laboratory stirrers and shakers, ultrasonic baths and probes, and highsheer homogenizers. All of these, however, have potential drawbacks.

Grinding

It is a somewhat disheartening fact that manual grinding with a pestle and mortar is still occurring on a routine basis in many laboratories. Not only does this make preparation a tedious and laborious process, it also poses some significant health and safety issues, particularly with potent active drug products.

Stirrers and shakers

Laboratory stirrers and shakers are routinely used to gently agitate solutions and encourage the dissolution process. Although they are relatively cost-effective and simple to use, throughput usually dictates the use of multiple units, which take up large areas of bench space. Complex controlled-release dosage forms also inevitably require extended periods of agitation, with dissolution times of several hours.

Ultrasonic bath

An ultrasonic bath or probe applies highfrequency sonic energy to encourage break down of the tablet structure and can be much faster than stirring or shaking. Pressure waves in the solution create and destroy small bubbles that release the energy as intense heat at the point of their collapse; an effect known as 'cavitation'.1 This process causes generalized heating of a solution, but the inadvertent focusing of sound waves can create intense 'hotspots', which leads to accelerated degradation of the formulation.

The location of ultrasonic processing equipment is also important as devices tend to be very noisy when in operation.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology Europe,
Click here